Sirt result, page-70

Please look back at my posts
I was a SRX believer, maybe I should put it in this way- I have invested in 90% of any pharma / biotech listed companies in asx that in phase 2 trial or above including long term holder in CSL, PNV, PRR, and etc. some I hold lots some just a small parcel depending on the risk due my knowledge in science , medical and pharma industry. I did make lots of money , I did lose money as well.

Investing in pharma stocks need lots of patience. Risk vs reward. All I can tell you is the trial results all it matters. Clearly SRX today published results didn't meet the primary endpoint. It is a fact!. Well it may be still a good therapeutic option for HCC , it become less attractive candidate. Then it means marketing and prices become extremely critical in achieving sales results. Margin will be squeezed by competitor drugs. And when it come to cancer treatment , survival is the top priority factor to consider.

I am not saying the next 2 trail results will not be good . However the risk become higher now than before. With this I have sold half of my holdings at open. I could be kicking myself but that's what I need to do to reduce my risk.
Dyor